scholarly journals Differential expression of leucine rich repeat containing 8 family member D in human epithelial ovarian cancer.

2021 ◽  
Author(s):  
Shahan Mamoor
Keyword(s):  
Ovarian Cancer ◽  
Epithelial Ovarian Cancer ◽  
Family Member ◽  
Fallopian Tube ◽  
Expression Profiles ◽  
Gynecologic Cancer ◽  
High Grade ◽  
Leucine Rich Repeat ◽  
Primary Tumors ◽  
Ovarian Cancers

Epithelial ovarian cancer (EOC) is the most lethal gynecologic cancer (1). We performed discovery of genes associated with epithelial ovarian cancer and of the high-grade serous ovarian cancer (HGSC) subtype, using published microarray data (2, 3) to compare global gene expression profiles of normal ovary or fallopian tube with that of primary tumors from women diagnosed with epithelial ovarian cancer or HGSC. We identified the gene encoding leucine rich repeat containing 8 family member D, LRRC8D, as among the genes whose expression was most different in epithelial ovarian cancer as compared to the normal fallopian tube. LRRC8D expression was significantly higher in high-grade serous ovarian tumors relative to normal fallopian tube. LRRC8D expression correlated with overall survival in patients with ovarian cancer. These data indicate that expression of LRRC8D is perturbed in epithelial ovarian cancers broadly and in ovarian cancers of the HGSC subtype. LRRC8D may be relevant to pathways underlying ovarian cancer initiation (transformation) or progression.

scholarly journals Differential expression of SLIT and NTRK-like family member 3 in human epithelial ovarian cancer.

2021 ◽  
Author(s):  
Shahan Mamoor
Keyword(s):  
Ovarian Cancer ◽  
Epithelial Ovarian Cancer ◽  
Family Member ◽  
Fallopian Tube ◽  
Expression Profiles ◽  
Gynecologic Cancer ◽  
Progression Free Survival ◽  
High Grade ◽  
Primary Tumors ◽  
Ovarian Cancers

Epithelial ovarian cancer (EOC) is the most lethal gynecologic cancer (1). We performed discovery of genes associated with epithelial ovarian cancer and of the high-grade serous ovarian cancer (HGSC) subtype, using published and public microarray data (2, 3) to compare global gene expression profiles of normal ovary or fallopian tube with that of primary tumors from women diagnosed with epithelial ovarian cancer or HGSC. We identified the gene encoding SLIT and NTRK-like family member 3, SLITRK3, as among the genes whose expression was most different in epithelial ovarian cancer as compared to the normal fallopian tube. SLITRK3 expression was significantly lower in high-grade serous ovarian tumors relative to normal fallopian tube. SLITRK3 expression correlated with progression-free survival in patients with ovarian cancer. These data indicate that expression of SLITRK3 is perturbed in epithelial ovarian cancers broadly and in ovarian cancers of the HGSC subtype. SLITRK3 may be relevant to pathways underlying ovarian cancer initiation (transformation) or progression.

scholarly journals Differential expression of acyl-CoA synthetase medium-chain family member 1 in human epithelial ovarian cancer.

2021 ◽  
Author(s):  
Shahan Mamoor
Keyword(s):  
Ovarian Cancer ◽  
Epithelial Ovarian Cancer ◽  
Family Member ◽  
Fallopian Tube ◽  
Expression Profiles ◽  
Gynecologic Cancer ◽  
High Grade ◽  
Primary Tumors ◽  
Medium Chain ◽  
Ovarian Cancers

Epithelial ovarian cancer (EOC) is the most lethal gynecologic cancer (1). We performed discovery of genes associated with epithelial ovarian cancer and of the high-grade serous ovarian cancer (HGSC) subtype, using published microarray data (2, 3) to compare global gene expression profiles of normal ovary or fallopian tube with that of primary tumors from women diagnosed with epithelial ovarian cancer or HGSC. We identified the gene encoding acyl-CoA synthetase medium-chain family member 1, ACSM1, as among the genes whose expression was most different in epithelial ovarian cancer as compared to the normal fallopian tube. ACSM1 expression was significantly lower in high-grade serous ovarian tumors relative to normal fallopian tube. ACSM1 expression correlated with overall survival in patients with ovarian cancer. These data indicate that expression of ACSM1 is perturbed in epithelial ovarian cancers broadly and in ovarian cancers of the HGSC subtype. ACSM1 may be relevant to pathways underlying ovarian cancer initiation (transformation) or progression.

scholarly journals Differential expression of PAGE family member 4 in human epithelial ovarian cancer.

2021 ◽  
Author(s):  
Shahan Mamoor
Keyword(s):  
Ovarian Cancer ◽  
Epithelial Ovarian Cancer ◽  
Family Member ◽  
Fallopian Tube ◽  
Expression Profiles ◽  
Gynecologic Cancer ◽  
Progression Free Survival ◽  
High Grade ◽  
Primary Tumors ◽  
Ovarian Cancers

Epithelial ovarian cancer (EOC) is the most lethal gynecologic cancer (1). We performed discovery of genes associated with epithelial ovarian cancer and of the high-grade serous ovarian cancer (HGSC) subtype, using published and public microarray data (2, 3) to compare global gene expression profiles of normal ovary or fallopian tube with that of primary tumors from women diagnosed with epithelial ovarian cancer or HGSC. We identified the gene encoding PAGE family member 4, PAGE4, as among the genes whose expression was most different in epithelial ovarian cancer as compared to the normal fallopian tube. PAGE4 expression was significantly lower in high-grade serous ovarian tumors relative to normal fallopian tube. PAGE4 expression correlated with progression-free survival in patients with p53 mutant ovarian cancer. These data indicate that expression of PAGE4 is perturbed in epithelial ovarian cancers broadly and in ovarian cancers of the HGSC subtype. PAGE4 may be relevant to pathways underlying ovarian cancer initiation (transformation) or progression.

scholarly journals Differential expression of leucine-rich repeat-containing 59 in human epithelial ovarian cancer.

2021 ◽  
Author(s):  
Shahan Mamoor
Keyword(s):  
Ovarian Cancer ◽  
Epithelial Ovarian Cancer ◽  
Fallopian Tube ◽  
Expression Profiles ◽  
Gynecologic Cancer ◽  
Progression Free Survival ◽  
High Grade ◽  
Leucine Rich Repeat ◽  
Primary Tumors ◽  
Ovarian Cancers

Epithelial ovarian cancer (EOC) is the most lethal gynecologic cancer (1). We performed discovery of genes associated with epithelial ovarian cancer and of the high-grade serous ovarian cancer (HGSC) subtype, using published microarray data (2, 3) to compare global gene expression profiles of normal ovary or fallopian tube with that of primary tumors from women diagnosed with epithelial ovarian cancer or HGSC. We identified the gene encoding leucine-rich repeat-containing 59, LRRC59, as among the genes whose expression was most different in epithelial ovarian cancer as compared to the normal fallopian tube. LRRC59 expression was significantly higher in high-grade serous ovarian tumors relative to normal fallopian tube. LRRC59 expression correlated with progression-free survival in patients with ovarian cancer. These data indicate that expression of LRRC59 is perturbed in epithelial ovarian cancers broadly and in ovarian cancers of the HGSC subtype. LRRC59 may be relevant to pathways underlying ovarian cancer initiation (transformation) or progression.

scholarly journals Differential expression of mex-3 RNA binding family member A in human epithelial ovarian cancer.

2021 ◽  
Author(s):  
Shahan Mamoor
Keyword(s):  
Ovarian Cancer ◽  
Epithelial Ovarian Cancer ◽  
Family Member ◽  
Fallopian Tube ◽  
Rna Binding ◽  
Expression Profiles ◽  
Gynecologic Cancer ◽  
High Grade ◽  
Primary Tumors ◽  
Ovarian Cancers

Epithelial ovarian cancer (EOC) is the most lethal gynecologic cancer (1). We performed discovery of genes associated with epithelial ovarian cancer and of the high-grade serous ovarian cancer (HGSC) subtype, using published and public microarray data (2, 3) to compare global gene expression profiles of normal ovary or fallopian tube with that of primary tumors from women diagnosed with epithelial ovarian cancer or HGSC. We identified the gene encoding mex-3 RNA binding family member A, MEX3A, as among the genes whose expression was most different in epithelial ovarian cancer as compared to the normal fallopian tube. MEX3A expression was significantly higher in high-grade serous ovarian tumors relative to normal fallopian tube. MEX3A expression correlated with overall survival in patients with ovarian cancer. These data indicate that expression of MEX3A is perturbed in epithelial ovarian cancers broadly and in ovarian cancers of the HGSC subtype. MEX3A may be relevant to pathways underlying ovarian cancer initiation (transformation) or progression.

scholarly journals Differential expression of thymocyte selection associated family member 2 in human epithelial ovarian cancer.

2021 ◽  
Author(s):  
Shahan Mamoor
Keyword(s):  
Ovarian Cancer ◽  
Epithelial Ovarian Cancer ◽  
Family Member ◽  
Fallopian Tube ◽  
Expression Profiles ◽  
Gynecologic Cancer ◽  
High Grade ◽  
Primary Tumors ◽  
Ovarian Cancers ◽  
Associated Family

Epithelial ovarian cancer (EOC) is the most lethal gynecologic cancer (1). We performed discovery of genes associated with epithelial ovarian cancer and of the high-grade serous ovarian cancer (HGSC) subtype, using published microarray data (2, 3) to compare global gene expression profiles of normal ovary or fallopian tube with that of primary tumors from women diagnosed with epithelial ovarian cancer or HGSC. We identified the gene encoding thymocyte selection associated family member 2, THEMIS2, as among the genes whose expression was most different in epithelial ovarian cancer as compared to the normal fallopian tube. THEMIS2 expression was significantly higher in high-grade serous ovarian tumors relative to normal fallopian tube. THEMIS2 expression correlated with overall survival in patients with ovarian cancer. These data indicate that expression of THEMIS2 is perturbed in epithelial ovarian cancers broadly and in ovarian cancers of the HGSC subtype. THEMIS2 may be relevant to pathways underlying ovarian cancer initiation (transformation) or progression.

scholarly journals Differential expression of shisa family member 6 in human epithelial ovarian cancer.

2021 ◽  
Author(s):  
Shahan Mamoor
Keyword(s):  
Ovarian Cancer ◽  
Epithelial Ovarian Cancer ◽  
Family Member ◽  
Fallopian Tube ◽  
Expression Profiles ◽  
Gynecologic Cancer ◽  
Progression Free Survival ◽  
High Grade ◽  
Primary Tumors ◽  
Ovarian Cancers

Epithelial ovarian cancer (EOC) is the most lethal gynecologic cancer (1). We performed discovery of genes associated with epithelial ovarian cancer and of the high-grade serous ovarian cancer (HGSC) subtype, using published and public microarray data (2, 3) to compare global gene expression profiles of normal ovary or fallopian tube with that of primary tumors from women diagnosed with epithelial ovarian cancer or HGSC. We identified the gene encoding shisa family member 6, SHISA6, as among the genes whose expression was most different in epithelial ovarian cancer as compared to the normal fallopian tube. SHISA6 expression was significantly lower in high-grade serous ovarian tumors relative to normal fallopian tube. SHISA6 expression correlated with progression-free survival in patients with p53 mutant ovarian cancer. These data indicate that expression of SHISA6 is perturbed in epithelial ovarian cancers broadly and in ovarian cancers of the HGSC subtype. SHISA6 may be relevant to pathways underlying ovarian cancer initiation (transformation) or progression.

scholarly journals Differential expression of leucine-rich repeat transmembrane neuronal 1 in human epithelial ovarian cancer.

2021 ◽  
Author(s):  
Shahan Mamoor
Keyword(s):  
Ovarian Cancer ◽  
Epithelial Ovarian Cancer ◽  
Fallopian Tube ◽  
Expression Profiles ◽  
Gynecologic Cancer ◽  
Gene Expression Profiles ◽  
High Grade ◽  
Leucine Rich Repeat ◽  
Primary Tumors ◽  
Ovarian Cancers

Epithelial ovarian cancer (EOC) is the most lethal gynecologic cancer (1). We performed discovery of genes associated with epithelial ovarian cancer and of the high-grade serous ovarian cancer (HGSC) subtype, using published microarray data (2, 3) to compare global gene expression profiles of normal ovary or fallopian tube with that of primary tumors from women diagnosed with epithelial ovarian cancer or HGSC. We identified the gene encoding leucine-rich repeat transmembrane neuronal 1, LRRTM1, as among the genes whose expression was most different in epithelial ovarian cancer as compared to the normal fallopian tube. LRRTM1 expression was significantly higher in high-grade serous ovarian tumors relative to normal fallopian tube. LRRTM1 expression correlated with overall survival in patients with ovarian cancer. These data indicate that expression of LRRTM1 is perturbed in epithelial ovarian cancers broadly and in ovarian cancers of the HGSC subtype. LRRTM1 may be relevant to pathways underlying ovarian cancer initiation (transformation) or progression.

scholarly journals Differential expression of tweety family member 3 in human epithelial ovarian cancer.

2021 ◽  
Author(s):  
Shahan Mamoor
Keyword(s):  
Ovarian Cancer ◽  
Epithelial Ovarian Cancer ◽  
Family Member ◽  
Fallopian Tube ◽  
Expression Profiles ◽  
Gynecologic Cancer ◽  
Gene Expression Profiles ◽  
High Grade ◽  
Primary Tumors ◽  
Ovarian Cancers

Epithelial ovarian cancer (EOC) is the most lethal gynecologic cancer (1). We performed discovery of genes associated with epithelial ovarian cancer and of the high-grade serous ovarian cancer (HGSC) subtype, using published microarray data (2, 3) to compare global gene expression profiles of normal ovary or fallopian tube with that of primary tumors from women diagnosed with epithelial ovarian cancer or HGSC. We identified the gene encoding tweety family member 3, TTYH3, as among the genes whose expression was most different in epithelial ovarian cancer as compared to the normal fallopian tube. TTYH3 expression was significantly higher in high-grade serous ovarian tumors relative to normal fallopian tube. TTYH3 expression correlated with overall survival in patients with ovarian cancer. These data indicate that expression of TTYH3 is perturbed in epithelial ovarian cancers broadly and in ovarian cancers of the HGSC subtype. TTYH3 may be relevant to pathways underlying ovarian cancer initiation (transformation) or progression.

scholarly journals Differential expression of leucine rich repeat containing 25 in human epithelial ovarian cancer.

2021 ◽  
Author(s):  
Shahan Mamoor
Keyword(s):  
Ovarian Cancer ◽  
Epithelial Ovarian Cancer ◽  
Fallopian Tube ◽  
Expression Profiles ◽  
Gynecologic Cancer ◽  
Gene Expression Profiles ◽  
High Grade ◽  
Leucine Rich Repeat ◽  
Primary Tumors ◽  
Ovarian Cancers

Epithelial ovarian cancer (EOC) is the most lethal gynecologic cancer (1). We performed discovery of genes associated with epithelial ovarian cancer and of the high-grade serous ovarian cancer (HGSC) subtype, using published microarray data (2, 3) to compare global gene expression profiles of normal ovary or fallopian tube with that of primary tumors from women diagnosed with epithelial ovarian cancer or HGSC. We identified the gene encoding leucine rich repeat containing 25, LRRC25, as among the genes whose expression was most different in epithelial ovarian cancer as compared to the normal fallopian tube. LRRC25 expression was significantly higher in high-grade serous ovarian tumors relative to normal fallopian tube. LRRC25 expression correlated with overall survival in patients with ovarian cancer. These data indicate that expression of LRRC25 is perturbed in epithelial ovarian cancers broadly and in ovarian cancers of the HGSC subtype. LRRC25 may be relevant to pathways underlying ovarian cancer initiation (transformation) or progression.

Sign in / Sign up

Export Citation Format

Share Document